Dr. Glazer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2505 East Paris Ave SE
Ste 100
Grand Rapids, MI 49546Phone+1 616-285-1200Fax+1 616-940-0864
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1988 - 1991
Advocate Illinois Masonic Medical CenterInternship, Transitional Year, 1987 - 1988
Yale School of MedicineClass of 1987
Certifications & Licensure
MI State Medical License 1991 - 2027
FL State Medical License 2003 - 2024
IL State Medical License 1987 - 1996
WI State Medical License 1988 - 1991- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
- Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 5 citationsRanibizumab Alters Levels of Intraocular Soluble Cytokine Receptors in Patients with Diabetic Macular Edema.Brandon Coughlin, Pratim Guha-Niyogi, Alla Sikorskii, Louis C. Glazer, Susanne Mohr
Current Eye Research. 2020-04-01 - 9 citationsA Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovasc...Stephen H Poor, Georges Weissgerber, Christopher M Adams, Harit Bhatt, David J Browning
American Journal of Ophthalmology. 2022-07-01 - 2 citationsDiabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy.Tim F Dorweiler, Arjun Singh, Aditya Ganju, Todd A Lydic, Louis C Glazer
Cell Metabolism. 2024-07-02
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Clinical Trial UpdateOctober 1st, 2018
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
